Arthneeti
All Q2 FY27 results →
ZH

Zota Health Care Ltd

Q2 FY27Pharmaceuticals & Biotechnology

Zota Health Care Q2 Results 2026 (FY27) investor presentation: Revenue & Margins

Q2 FY27 investor presentation: what the company reported on revenue, margins and capex.

Price₹1,280
Market cap₹4.4K Cr
Updated28 Oct 2026
Read3 min read

Zota Health Care Ltd Q2 FY27 key numbers

Revenue
Revenue from Operations for Q2FY27 is ₹19,933.14 lakhs, up 54.58% YoY from ₹12,894.82 lakhs in Q2FY26.

As stated in Zota Health Care Ltd's Q2 FY27 investor presentation · published 28 Oct 2026. Reported figures, not investment advice.

Based on Zota Health Care Ltd's Q2 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.

The short version

Revenue from Operations for Q2FY27 is ₹19,933.14 lakhs, up 54.58% YoY from ₹12,894.82 lakhs in Q2FY26. Q2FY27 Financials: - EBITDA: ₹791.72 lakhs (margin 3.97%) - Operating Profit: ₹306.03 lakhs (margin 1.54%) - Profit After Tax (PAT): -₹2,596.01 lakhs - Year-on-Year (YoY) Change (Q2FY27 vs Q2FY26): - EBITDA improved from ₹795.71 lakhs (6.17% margin) in Q2FY26 to ₹791.72 lakhs (3.97% margin) in Q2FY27 (decline in margin) - Operating Profit declined from ₹632.06 lakhs (4.90% margin) to ₹306.03 lakhs (1.54% margin) - PAT worsened from -₹1,619.37 lakhs to -₹2,596.01 lakhs - Margin Outlook: - Management commentary states a focus on sustainable and disciplined growth, accelerating store additions while maintaining strong store-level productivity, operating efficiency, and cash generation.

From Zota Health Care Ltd's Q2 FY27 earnings-call transcript · updated 28 Oct 2026.

Revenue & Sales Performance

  • Revenue from Operations for Q2FY27 is ₹19,933.14 lakhs, up 54.58% YoY from ₹12,894.82 lakhs in Q2FY26.
  • Davaindia Sales rose to ₹16,846.81 lakhs in Q2FY27, a 76.25% YoY increase from ₹9,558.59 lakhs in Q2FY26.
  • Everyday Herbal Group revenue increased 78.99% YoY to ₹806.79 lakhs in Q2FY27 from ₹450.75 lakhs in Q2FY26.
  • Export Sales were ₹470.09 lakhs in Q2FY27, down from ₹1,094.98 lakhs in Q2FY26.
  • Domestic Sales were ₹2,459.13 lakhs, up from ₹1,790.50 lakhs in Q2FY26.

2 more points from Zota Health Care Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

  • Q2FY27 Financials:
  • EBITDA: ₹791.72 lakhs (margin 3.97%)
  • Operating Profit: ₹306.03 lakhs (margin 1.54%)
  • Profit After Tax (PAT): -₹2,596.01 lakhs
  • Year-on-Year (YoY) Change (Q2FY27 vs Q2FY26):
  • EBITDA improved from ₹795.71 lakhs (6.17% margin) in Q2FY26 to ₹791.72 lakhs (3.97% margin) in Q2FY27 (decline in margin)
  • Operating Profit declined from ₹632.06 lakhs (4.90% margin) to ₹306.03 lakhs (1.54% margin)
  • PAT worsened from -₹1,619.37 lakhs to -₹2,596.01 lakhs
  • Margin Outlook:

2 more points from Zota Health Care Ltd's call on margins

Create a free account to keep reading this call

Capital Expenditure Plans

It primarily focuses on operational performance, financial results, store expansion (particularly for Davaindia), and business verticals such as Domestic, Export, and Everyday Herbal. The expansion of stores (Davaindia) is discussed, but without capex values or project-level specifics.

Top-ranked in Pharmaceuticals & Biotechnology

Ranked on what management guided this quarter

Guidance-ranked
1KRM Ayurveda
Rev 1Mar 1
2Accretion Pha.
Rev 1Mar 2
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 1Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Zota Health Care Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

See what Zota Health Care Ltd said on order book & pipeline — free account, 30 seconds.

Zota Health Care Ltd — Quarterly revenue & net profit

Revenue Net profit Net loss
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26

Q2 FY27 figures are not in this chart yet. Latest shown: Mar 2026 (Q4 FY26). The Q2 FY27 numbers from the filing are in the analysis on this page.

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹163 Cr, net loss ₹14 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Continue your research

What Zota Health Care Ltd's management said in earlier quarters

Others in Pharmaceuticals & Biotechnology this season

  • Sudeep Pharma Ltd (Q2 FY27)

    Q2 FY27 Revenue from Operations:** Rs 196.7 crore . Key investor presentation takeaways from Sudeep Pharma Ltd's Q2 FY27 investor presentation — and how it rank

  • Jagsonpal Pharmaceuticals Ltd (Q2 FY27)

    Q2FY27 consolidated revenue: ₹964 Mn, up 29% YoY . Key investor presentation takeaways from Jagsonpal Pharmaceuticals Ltd's Q2 FY27 investor presentation — and

  • FDC (Q2 FY27)

    47,303 lakhs in Q2 September 2025 (approximately 20.9% YoY growth). Key results statement takeaways from FDC Ltd's Q2 FY27 results statement — and how it ranks

  • Indoco Remedies Ltd (Q2 FY27)

    Consolidated revenues for Q2 FY 2026-27 are ₹5,069 million, up 7.4% year-on-year (YoY) from ₹4,718 million in the same quarter last year. Key results statement

Compare:vs Sun Pharma.Inds.vs Divi's Lab.vs Torrent Pharmaceuticals Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Zota Health Care Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Zota Health Care Ltd Q2 FY27 results?

Revenue from Operations for Q2FY27 is ₹19,933.14 lakhs, up 54.58% YoY from ₹12,894.82 lakhs in Q2FY26. Q2FY27 Financials: - EBITDA: ₹791.72 lakhs (margin 3.97%) - Operating Profit: ₹306.03 lakhs (margin 1.54%) - Profit After Tax (PAT): -₹2,596.01 lakhs - Year-on-Year (YoY) Change (Q2FY27 vs Q2FY26): - EBITDA improved from ₹795.71 lakhs (6.17% margin) in Q2FY26 to ₹791.72 lakhs (3.97% margin) in Q2FY27 (decline in margin) - Operating Profit declined from ₹632.06 lakhs (4.90% margin) to ₹306.03 lakhs (1.54% margin) - PAT worsened from -₹1,619.37 lakhs to -₹2,596.01 lakhs - Margin Outlook: - Management commentary states a focus on sustainable and disciplined growth, accelerating store additions while maintaining strong store-level productivity, operating efficiency, and cash generation.

What is Zota Health Care Ltd share price analysis?

Zota Health Care Ltd currently shows a neutral. The stock trades at a P/E of N/A with a market cap of ₹4,434 Cr. Investors should review the full earnings analysis for detailed insights.

Keep Zota Health Care Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.